Hancock Jaffe Laboratories, Inc. (HJLI) has 11 open-market insider trades by 6 insiders since 2019. The most active filer is Biodyne Holding, S.A..
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Biodyne Holding, S.A. | — | — | 4 | $2.1M | 2020-08-21 |
| Francis Duhay | Dir | — | 1 | $101K | 2021-05-17 |
| Robert Andrew Berman | CEO | — | 3 | $66K | 2021-05-18 |
| Robert Gray | Dir | — | 1 | $13K | 2021-06-16 |
| Matthew Jenusaitis | Dir | — | 1 | $10K | 2021-08-25 |
| Marc H. Glickman | SVP & Chief Medical Officer | — | 1 | $9K | 2021-05-21 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Matthew Jenusaitis | Director | Buy | $10K | 2021-08-25 |
| Robert Gray | Director | Buy | $13K | 2021-06-16 |
| Marc H. Glickman | SVP & Chief Medical Officer | Buy | $9K | 2021-05-21 |
| Robert Andrew Berman | CEO | Buy | $16K | 2021-05-18 |
| Francis Duhay | Director | Buy | $101K | 2021-05-17 |
| Biodyne Holding, S.A. | — | Sell | $787K | 2020-06-11 |
Companies that share insiders with HJLI, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Biodyne Holding, S.A. | 10% Owner | Sell | $74K | 2020-06-02 |
| Biodyne Holding, S.A. | 10% Owner | Sell | $349K | 2019-06-07 |
| Biodyne Holding, S.A. | 10% Owner | Sell | $918K | 2019-06-07 |
| Robert Andrew Berman | CEO | Buy | $25K | 2019-03-12 |
| Robert Andrew Berman | CEO | Buy | $25K | 2019-03-12 |